Related by context. All words. (Click for frequent words.) 69 arthritis PsA 68 treat hyperphosphatemia 67 essential thrombocythemia ET 67 CTAP# 67 mitoxantrone plus 67 patientswith 67 dasatinib Sprycel ® 67 catheter occlusion 67 metastatic malignant 67 toenail onychomycosis 67 acetonide FA 67 vinorelbine tartrate 66 diarrhea predominant irritable 66 metastatic GIST 66 chronic thromboembolic pulmonary 66 Adjunctive 66 prokinetic agent 66 recurrent glioblastoma multiforme 66 rheumatoid arthritis RA psoriatic 66 relapsed leukemia 66 occlusion PAO 66 Initiates Clinical Trial 66 Amgen Neulasta R 66 relapsing remitting MS RRMS 66 BCG refractory carcinoma 66 hyperphenylalaninemia HPA due 66 rheumatoid arthritis osteoarthritis ankylosing 66 reduce serum phosphate 66 Myelodysplastic Syndrome MDS 66 tumors GIST 66 hepatorenal syndrome 66 vapreotide acetate 66 AVAPRO 66 IV Busulfex 66 steroid refractory ulcerative 66 Nebulized 65 Tramiprosate ALZHEMED TM 65 myocardial infarction ventricular fibrillation 65 Investigational Treatment 65 novel synthetic peptide 65 non splenectomized 65 secondary hyperparathyroidism SHPT 65 exocrine pancreatic insufficiency EPI 65 Dementia Related Psychosis 65 Myelofibrosis 65 either acutely decompensated 65 Renal Replacement Therapy 65 immunomodulatory therapy 65 refractory NSCLC 65 LymphoStat B belimumab 65 relapsed multiple myeloma 65 secondary hyperparathyroidism 65 acute peripheral arterial 65 TO AVOID PREGNANCY WHILE 65 treat chronic sinusitis 65 post herpetic neuralgia PHN 65 oropharyngeal candidiasis OPC 65 Initiates Enrollment 65 R lenalidomide 65 denileukin diftitox 65 thalidomide Thalomid 64 ergot derivatives 64 chronic eosinophilic leukemia 64 tuberous sclerosis TS 64 ® lenalidomide 64 Amgen Neulasta ® 64 Intravenous immunoglobulin 64 thetreatment 64 polycythemia vera essential thrombocythemia 64 metastatic gastric 64 myelodysplastic myeloproliferative diseases 64 Relapsed Refractory 64 opioid induced bowel dysfunction 64 lexidronam injection 64 R Saizen R 64 SNT-MC#/idebenone 64 Severe Sepsis 64 COLAZAL ® 64 macular edema secondary 64 deep venous thromboses 64 candesartan cilexetil 64 Lupus Nephritis 64 metastatic malignant melanoma 64 VELCADE melphalan 64 TNF Tumor Necrosis Factor 64 Systemic lupus erythematosus SLE 64 orally inhaled migraine 64 Mg Uk 64 Initiate Phase 64 RhuDex TM 64 constipation OIC 64 somatostatin analog 64 venous stasis ulcers 64 receiving VELCADE 64 thrombotic disorders 64 idiopathic thrombocytopenic purpura ITP 64 relapsing multiple sclerosis 64 Phase #b/#a clinical 64 Meets Primary Endpoint 64 Aflibercept 64 rheumatoid arthritis psoriatic arthritis 64 ACTEMRA TM 64 Acute Renal Failure 64 immune thrombocytopenic purpura 64 Begins Dosing 64 cetuximab Erbitux R 64 HYVISC R 64 hypertrichosis occurred 64 symptomatic neurogenic orthostatic hypotension 64 Plaque Psoriasis 64 topically administered 64 IAP inhibitor 63 overactive bladder syndrome 63 Mg Usa 63 Initiates Phase II 63 phase III isavuconazole 63 hypereosinophilic syndrome 63 PAOD 63 vaginal candidiasis 63 stage IIIB 63 TASKi3 63 atypical Hemolytic Uremic Syndrome 63 generation purine nucleoside 63 RhuDex ® 63 Acute Bacterial Sinusitis ABS 63 milrinone 63 recurrent malignant glioma 63 ankylosing spondylitis AS 63 calcineurin inhibitor 63 SYN# 63 erlotinib Tarceva ® 63 plus prednisone prednisolone 63 humanized interleukin 6 63 oral anti arrhythmic 63 myeloid metaplasia 63 methylnaltrexone bromide 63 Wafer polifeprosan 63 refractory chronic lymphocytic 63 Safinamide 63 pregabalin Lyrica 63 Hypotension 63 Atypical Hemolytic Uremic Syndrome 63 relapsed MM 63 LymphoStat B TM 63 INSPIRE Trial Phase III 63 personalized cellular immunotherapy 63 Monopril 63 GW# [003] 63 oral candidiasis 63 milnacipran HCl 63 primary dysmenorrhea 63 peritumoral brain edema 63 Soft Tissue Sarcoma 63 Cutaneous T 63 PROCRIT ® 63 gastrointestinal mucositis 63 Diabetic Macular Edema DME 63 NASH Huntington 63 Acute Exacerbations 63 EnteroMedics proprietary neuroblocking technology 63 Orally administered 63 Detrol Detrol LA 63 esophageal candidiasis 63 mertansine 63 dyslipidemia hypertension diabetes 63 cisplatin gemcitabine 63 CYT# potent vascular disrupting 63 delivers fluocinolone acetonide FA 63 pouchitis 63 MOVIPREP R 63 Dosa suffers 63 topical gel formulation 63 unresectable HCC 63 kidney urologic 63 erythematosus 63 relapsed refractory multiple myeloma 63 de novo kidney transplant 63 Gastrointestinal GI 63 Oral Fingolimod 63 Ecallantide 63 fistulizing Crohn disease 63 primary immunodeficiency PI 63 dilated cardiomyopathy DCM 63 metastatic colorectal carcinoma 63 sunitinib Sutent 63 PEGINTRON TM 63 treat secondary hyperparathyroidism 62 Fludara ® 62 Novel Oral 62 Crofelemer budesonide foam 62 Daclizumab 62 Cryopyrin Associated Periodic Syndromes 62 cell lymphoma CTCL 62 pulmonary hypertension PH 62 Major Depressive Disorder MDD 62 Patients Treated With 62 Ribavirin causes 62 Kepivance 62 Vascular Disrupting Agent 62 herpetic keratitis 62 beta 1a 62 congenital ichthyosis 62 Vitrasert R 62 benign prostatic hypertrophy BPH 62 Successfully Completes Phase 62 treat benign prostatic 62 Cloretazine 62 inhalation powder 62 nicardipine 62 ALN HPN 62 Initiates Clinical 62 continuous ambulatory peritoneal 62 Percutaneous vertebroplasty 62 Metastatic Melanoma 62 Acute Myeloid Leukemia AML 62 Idiopathic Pulmonary Fibrosis IPF 62 pamidronate 62 Fx #A 62 Intravitreal 62 alpha1 antitrypsin deficiency 62 Receives Orphan Drug Designation 62 Phase 2b Clinical Trial 62 postsurgical pain 62 ORENCIA ® 62 metastatic carcinoid 62 targeted radiotherapeutic 62 intranasal formulation 62 Systemic Lupus Erythematosus SLE 62 Bronchiectasis 62 PEGylated anti 62 nucleoside analog 62 adalimumab Humira 62 Diffuse Large B 62 bone marrow reticulin deposition 62 developing Bicifadine serotonin 62 mild hepatic impairment 62 Hylan GF 62 octreotide implant 62 anticholinergic agents 62 painful diabetic neuropathy 62 familial amyloidotic polyneuropathy FAP 62 Motexafin Gadolinium 62 cell carcinoma RCC 62 Prochymal TM 62 Serostim ® 62 FUSILEV enhances 62 psoriasis rheumatoid arthritis 62 cystoid macular edema 62 Dyskinesia 62 IMiDs ® 62 biliary tract cancer 62 retinal vein occlusion induced 62 markets HP Acthar 62 Investigational Oral 62 peripherally acting 62 IN PATIENTS WITH 62 Frozen Shoulder syndrome Adhesive 62 Abrupt discontinuation 62 Kamada AAT 62 included neutropenia anemia 62 opioid induced constipation OIC 62 pan HDAC inhibitor 62 leukemia AML 62 Phase IIa Clinical Trial 62 Newly Diagnosed Multiple Myeloma 62 neurogenic orthostatic hypotension 62 ANCA associated 62 rALLy clinical trial 62 Lixivaptan 62 selective phosphodiesterase 62 induced macular edema 62 Refractory Hodgkin Lymphoma 62 Advanced Melanoma 62 HBeAg + 62 Acute Myelogenous Leukemia AML 62 carcinoma mCRC 62 hypoxia activated prodrug 62 active ankylosing spondylitis 62 Naive Patients 62 4mg/kg 62 hypervascular tumors 62 docetaxel Taxotere ® 62 sunitinib Sutent ® 62 psoriatic arthritis PsA 62 Fibrillex TM 62 chronic rheumatic 62 receptor tyrosine kinase inhibitor 62 baminercept 62 chronic ITP patients 62 Rheumatoid 62 CB2 selective receptor agonist 62 Deferiprone 62 overactive bladder AA# 62 headache abdominal pain 62 bronchial hyperresponsiveness 62 oral prodrug 62 lintuzumab SGN 62 triggers apoptosis programmed 62 NYHA Class II 62 brand ciclesonide HFA 62 abacavir Ziagen 62 PNP inhibitor 62 recurrent sinusitis 62 histone deacetylase HDAC inhibitor 62 Benign Prostatic Hyperplasia BPH 62 prostate cancer HRPC 62 PEGylated Fab fragment 62 immune thrombocytopenic purpura ITP 62 * olmesartan medoxomil 62 neutropenia dehydration dyspnea 62 advanced metastatic renal 62 receiving XGEVA 62 autoimmune uveitis 62 R sorafenib tablets 62 Familial Adenomatous Polyposis FAP 62 debilitating complication 62 hemodialysis peritoneal dialysis 62 Completes Enrollment 62 neuropathic pain spasticity 62 Shellgel TM injectable viscoelastic 62 basiliximab 62 Neulasta R 61 unstable angina UA 61 Decitabine 61 BUPHENYL R sodium phenylbutyrate 61 interferon alpha IFN 61 Granted Orphan Drug 61 Tiuxetan 61 commercialize deforolimus 61 systemic juvenile idiopathic 61 Oropharyngeal Candidiasis 61 modified glutathione analog 61 dihydrochloride 61 peripheral arterial occlusive disease 61 gastrointestinal GI motility disorders 61 orally administered inhibitor 61 severe oral mucositis 61 FOLOTYN ® 61 Peginterferon alfa 2b 61 neurogenic bladder 61 ADP receptor antagonist 61 FDA APPROVES 61 alfa 2a 61 Bucindolol 61 Liprotamase 61 mycophenolate mofetil MMF 61 IMiDs R 61 Occlusive Disease 61 Achieves Primary Endpoint 61 lupus erythematosus 61 refractory cutaneous T 61 hyperplasia BPH 61 Host Disease 61 Chronic lymphocytic leukemia 61 Dacogen decitabine 61 metastatic pancreatic 61 AA Amyloidosis 61 systemic hypotension 61 Vidaza azacitidine 61 MAGE A3 ASCI 61 intravenous RSD# 61 unresectable locally advanced 61 Degarelix 61 Initiate Clinical Trial 61 ALVESCO R 61 interferon alpha IFN alpha 61 transplantation HCT 61 post operative ileus 61 interstitial nephritis 61 intravesical infusion therapy 61 Complicated Skin 61 Castration Resistant Prostate Cancer 61 Inhalation Aerosol 61 pan histone deacetylase 61 Navelbine ® 61 aripiprazole Abilify 61 aldehyde dehydrogenase ALDH2 deficiency 61 metastatic hormone refractory 61 Diabetic Retinopathy DR 61 Gel repository corticotropin injection 61 Romiplostim 61 cutaneous T 61 Systemic Sclerosis 61 Renal Impairment 61 epoprostenol 61 apomorphine hydrochloride 61 Initiates Phase III 61 unresectable tumors 61 Mycophenolate Mofetil 61 subcutaneous immunoglobulin 61 NAVISTAR R 61 diabetic gastroparesis 61 Pulmonary Arterial Hypertension PAH 61 CRRT 61 PI3K/Akt pathway inhibitor 61 pancreatic insufficiency 61 Interferon beta 61 pralatrexate injection folate analogue 61 CTAP# Capsules 61 NMIBC 61 Sevelamer 61 Simulect 61 oxypurinol 61 diabetic peripheral neuropathy DPN 61 Pyridorin TM 61 YONDELIS 61 refractory acute myeloid 61 CALGB # [002] 61 Dual Opioid 61 hereditary deficiency 61 CIMZIA TM certolizumab pegol 61 non CF bronchiectasis 61 paclitaxel Taxol R 61 undergoing hematopoietic stem 61 IIb clinical trial 61 chronic renal disease 61 overt nephropathy 61 Percutaneous Transluminal Coronary Angioplasty 61 TAXUS Element Paclitaxel Eluting 61 FACTIVE ® 61 Bystolic nebivolol 61 Xeloda ® 61 metastatic neuroendocrine tumors 61 SPRYCEL ® 61 percutaneous transluminal coronary angioplasty 61 ILUVIEN ® 61 assessing T DM1 61 allogeneic hematopoietic cell 61 severe gastroparesis 61 interstitial pneumonitis 61 chronic constipation CC 61 complement inhibitor eculizumab 61 vWD 61 diarrhea fatigue asthenia 61 miconazole Lauriad ® 61 multiple myeloma MM 61 Intra arterial 61 unresectable stage 61 Aryplase 61 Phase 2a Clinical Trial 61 Known hypersensitivity 61 evaluating picoplatin 61 Zorbtive TM 61 pediatric Crohn disease 61 BENICAR 61 Paroxysmal Nocturnal Hemoglobinuria PNH 61 gemtuzumab ozogamicin 61 Cannabinor 61 Panzem ® 61 budesonide foam 61 lumiliximab 61 Chronic Myelogenous Leukemia CML 61 Provectus Pharmaceuticals specializes 61 MKC# MT 61 refractory colorectal cancer 61 MVA HPV IL2 61 papillary renal cell carcinoma 61 Diabetic Foot Ulcer 61 Lupus nephritis 61 occlusion CRVO 61 PLX STROKE targeting 61 cystic fibrosis bronchiectasis 61 Diabetic Neuropathy 61 Wearable Artificial Kidney WAK 61 metastatic colorectal 61 memantine HCl 61 refractory gout 61 Fludarabine 61 acute bronchospasm 61 status asthmaticus 61 Glioblastoma Multiforme 61 Temodar ® 61 TLK# 61 Zenvia ™ 61 exocrine pancreatic insufficiency 61 investigational immunotherapy 61 Rebif interferon beta 1a 61 Xyfid TM 61 EVIZON ™ 61 Fabry Disease 61 gets USFDA nod 61 sorafenib tablets 61 valproate sodium 61 PPAR gamma agonist 61 naïve HCV 61 OMNARIS HFA 61 JAK2 Inhibitor 61 mild renal insufficiency 61 post herpetic 61 TELINTRA 61 Pegloticase 61 chronic myocardial ischemia 61 Omacetaxine 61 comparator arm 60 targeted antifolate 60 relapsed CLL 60 develop HBV reactivation 60 liver resection surgeries 60 cyclophosphamide chemotherapy 60 anthracyclines taxanes 60 headache nasopharyngitis 60 SinuNase TM 60 Recurrent Glioblastoma 60 mycophenolate 60 Hormone Refractory Prostate Cancer 60 NAGS deficiency 60 generation rotary VAD 60 stage IIIb IV 60 plus DOXIL 60 ATACAND 60 paclitaxel poliglumex 60 aneurysms AAA 60 novel emulsion formulation 60 antibody MAb 60 Perforomist ™ Inhalation Solution 60 chronic myeloid 60 oral ghrelin agonist 60 steroid refractory 60 rasagiline tablets 60 Melphalan 60 Enzastaurin 60 anti inflammatory NSAID 60 acute intermittent porphyria 60 Neovascular Age Related Macular 60 disease GERD 60 advanced medullary thyroid 60 acquired pneumonia HAP 60 purpura ITP 60 KRN# 60 abacavir lamivudine 60 manufactures minimally invasive 60 idiopathic thrombocytopenic purpura 60 Advanced Renal Cell 60 Microwave Ablation System 60 postherpetic neuralgia PHN 60 argatroban 60 urethral bulking agent 60 Acute Myeloid Leukaemia AML 60 allogeneic hematopoietic stem cell 60 constipation predominant irritable bowel 60 BUPHENYL 60 mGluR2 positive 60 non resectable 60 RANK Ligand inhibitor 60 taxane resistant 60 EFFEXOR XR 60 Vacuum Assisted Closure 60 inhaled liposomal ciprofloxacin 60 virus HCV protease inhibitor 60 reslizumab 60 ACTIQ ® 60 non nucleoside inhibitor 60 PsA 60 benign prostatic hypertrophy 60 patients receiving myelosuppressive 60 TAXOTERE R 60 Natalizumab 60 ThermoDox R 60 aflibercept VEGF Trap 60 diabetic neuropathic pain 60 Silodosin 60 bleeding pallor 60 Evoltra ® 60 levodopa induced 60 rhIGF-I/rhIGFBP-3 60 Eculizumab 60 nonmyeloablative 60 Pyridorin 60 systemic RNAi therapeutic 60 Personalized Immunotherapy 60 chills fever headache 60 chronic immune thrombocytopenic 60 EVIZON TM 60 PRN FDA Approves 60 ALVESCO ® 60 biologic DMARD 60 dasatinib Sprycel 60 chemoradiation therapy 60 Ceflatonin R 60 Adjunctive Therapy 60 Clolar ® 60 Pharmacokinetics PK 60 FSE FME 60 Pemetrexed 60 GRNOPC1 contains 60 eritoran 60 distal embolization thrombus formation 60 terlipressin 60 Bayer HealthCare Onyx Pharmaceuticals 60 albiglutide 60 Kit CD# positive 60 midstage clinical 60 alpha interferons 60 2 methoxyestradiol 60 targeting miR 60 sapropterin dihydrochloride Tablets 60 liposomal formulation 60 Auxilium transmucosal film 60 Hsp# Inhibitor 60 6R BH4 60 Acute Ischemic Stroke 60 Friedreich Ataxia FRDA 60 Tasimelteon 60 HeFH 60 cyclophosphamide methotrexate 60 gastrointestinal stromal tumor GIST 60 medically refractory 60 hyaluronidase enzyme 60 lymphocytic leukemia 60 Phase IIb Trial 60 refractory myeloma 60 haematologic 60 pentostatin 60 COPD asthma 60 hemorrhagic cystitis 60 descending thoracic 60 Infusion Reactions Severe 60 autoantibody positive 60 ulcerative colitis Crohn disease 60 opioid naive 60 included exfoliative dermatitis 60 Mitral Regurgitation 60 Solesta TM 60 cannabinor 60 certolizumab 60 systemic autoimmune 60 Heterozygous Familial Hypercholesterolemia 60 AMEVIVE 60 Teriflunomide 60 occlusive disease 60 oral beclomethasone dipropionate 60 Troxatyl 60 HepDirect prodrug 60 PEG IFN 60 delta gamma agonist 60 IMiDs ® compound 60 vinca alkaloid 60 stable angina pectoris 60 LHRH receptor positive 60 PresbyLens ® 60 PEGylated interferon beta 1a 60 selective A2A adenosine receptor 60 Chronic Sinusitis 60 PKC# 60 GEM OS2 60 Progressive Multifocal Leukoencephalopathy 60 MGd 60 oral nucleoside analogue 60 AKT inhibitor 60 Gets FDA Clearance 60 including cyclosporine methotrexate 60 lenalidomide Revlimid R 60 CIPN 60 Secondary Hyperparathyroidism 60 Irinotecan 60 Myelodysplastic Syndrome 60 MIRAPEX 60 Non Alcoholic Steatohepatitis 60 hyperlipidemia hypertension 60 benign prostatic hyperplasia enlarged 60 epilepsy neuropathic pain 60 Noxafil 60 Syndrome LEMS 60 Behcet uveitis 60 Relapsing Remitting Multiple Sclerosis 60 visilizumab 60 salmeterol fluticasone 60 refractory acute promyelocytic 60 adult periodontitis 60 Azmacort R 60 tumor angiogenesis inhibitors 60 idursulfase 60 endoluminal stent graft 60 bacterial exacerbation 60 TRIOLEX HE# APOPTONE HE# 60 Cleviprex TM clevidipine 60 cytomegalovirus immune globulin 60 Prolongs Survival 60 acute mania 60 formerly LymphoStat B 60 Beclomethasone 60 forodesine 60 accumulate preferentially 60 itraconazole Sporanox 60 Microplasmin 60 bevacizumab Avastin R 60 Dose Ranging Study 60 Generx TM 60 SUPPRELIN R LA 60 drug NP2 Enkephalin 60 Velcade bortezomib 60 Angioedema 60 undergoing radical cystectomy 60 renal failure interstitial lung 60 relapsed refractory AML 60 PROCTOCORT R 60 Alpha interferons including 60 Host Disease GvHD 60 Telintra 60 dextromethorphan quinidine 60 castrate resistant prostate cancer 60 acyclovir Zovirax 60 dopamine partial agonist 60 lung esophageal 60 alemtuzumab Campath 60 Dupuytren Disease 60 Remicade infliximab 60 oral antidiabetic medication 60 DEB# 60 R vitespen 60 mild vasodilator 60 ADL# novel 59 evaluate ZFP Therapeutic 59 sodium stibogluconate 59 evaluating tivozanib 59 aMCI precursor 59 Lymphocytic 59 Aeolus Pharmaceuticals Announces 59 receiving chemoradiation therapy 59 AGGRASTAT R Injection tirofiban 59 ketolide antibiotic 59 Vicinium TM 59 Delayed Graft Function 59 Bosutinib 59 Endologix Powerlink System 59 neurodegenerative disorder characterized 59 Actonel risedronate 59 cromolyn sodium 59 unresectable liver cancer 59 adult chronic ITP 59 estramustine 59 immuno inflammatory diseases 59 Annamycin 59 RhuDex R 59 DDP# 59 reteplase 59 polyneuropathy CIDP 59 cilengitide 59 Submits NDA 59 interstitial brachytherapy 59 immune idiopathic thrombocytopenic 59 advanced hepatocellular carcinoma 59 AAG geldanamycin analog 59 undergoing elective percutaneous 59 AGILECT R 59 Doxil ® 59 sodium benzoate prescription 59 MKC# 59 SHPT 59 small molecule tyrosine 59 Pafuramidine 59 polyneuropathy HIV DSP 59 imatinib Gleevec ® 59 Sezary syndrome 59 malignant ascites 59 leukotriene receptor antagonist 59 cutaneous lupus 59 interstitial cystitis chronic 59 valsartan amlodipine 59 humanised monoclonal antibody 59 HP Acthar Gel repository 59 RezularTM 59 taxane chemotherapy administered 59 diabetic kidney 59 Fibromyalgia Syndrome 59 factor TNF receptor 59 erythema nodosum 59 SSc 59 Completes Patient Enrollment 59 Pazopanib 59 omega interferon 59 volociximab 59 parathyroid carcinoma 59 Hepatocellular Carcinoma HCC 59 PROCRIT R 59 Ozarelix 59 vaso occlusive crisis 59 Lambert Eaton Myasthenic 59 Cimzia TM 59 CD3 monoclonal antibody 59 MIRAPEX ER 59 anti PlGF 59 fallopian tube carcinoma 59 HIV coinfected 59 PD LID 59 stem cell engraftment 59 solifenacin succinate 59 recurrent genital herpes 59 recurrent glioblastoma 59 sorafenib Nexavar 59 gastrointestinal stromal tumors GIST 59 Central Retinal Vein 59 Hydrochlorothiazide Tablets 59 nephropathic cystinosis cystinosis 59 recurrent epithelial ovarian 59 Lubiprostone 59 Hyperphosphatemia 59 Patients Receiving 59 systemic anaplastic large 59 chronic idiopathic thrombocytopenic purpura 59 BENICAR HCT 59 Certolizumab pegol 59 trastuzumab Herceptin R 59 bullous 59 multiple sclerosis Crohn disease 59 Dupuytren Contracture 59 mRCC 59 asthma emphysema bronchitis 59 Phase IIb Clinical Trial 59 CLL SLL 59 FASLODEX 59 XIAFLEX ® 59 Oral Calcitonin 59 ELADUR ™ 59 5 fluorouracil leucovorin 59 cerebrovascular disorders 59 INTEGRILIN R 59 DPP4 inhibitor 59 riociguat 59 non resectable metastatic 59 BrachySil ™ 59 treatment naïve genotype 59 headache nausea diarrhea 59 HIV distal sensory 59 dopaminergic therapy 59 Anthracycline 59 mecasermin 59 VitiGam 59 syndrome IBS 59 rusalatide acetate 59 MetroGel 59 Rituxan rituximab 59 Budesonide foam crofelemer 59 somatostatin analogue 59 gastrointestinal stromal 59 Commences Phase 59 malignant pheochromocytoma 59 SUTENT ® 59 severe malignant osteopetrosis 59 treatment naive genotype 59 Nonalcoholic fatty liver 59 balsalazide disodium Capsules 59 Disease Modifying 59 recurrent NSCLC 59 Flomax tamsulosin 59 radiotherapy RT 59 phase IIb clinical 59 pemphigus vulgaris 59 lamotrigine Lamictal 59 mineralocorticoid receptor 59 beclomethasone dipropionate 59 neovascular diseases 59 Tyrosine Kinase Inhibitor 59 Granulocyte Colony Stimulating Factor 59 prostate TURP 59 Acute Coronary Syndromes ACS 59 ST Elevation Myocardial 59 hormone refractory metastatic prostate 59 administered intranasally 59 chronic opioid 59 pioglitazone hydrochloride 59 lucinactant 59 AEGR 59 recombinant tissue plasminogen 59 Boehringer Ingelheim Mirapex 59 Edoxaban 59 Adjuvant Treatment 59 sacral nerve stimulation 59 selective antagonist 59 ara C 59 inhaled formulation 59 smoldering multiple myeloma 59 Acute Decompensated Heart Failure 59 Chronic Heart Failure 59 HCV RNA polymerase 59 Reclast zoledronic acid 59 icatibant 59 plasma kallikrein inhibitor 59 Interferon beta 1a 59 Frozen Shoulder Syndrome 59 diarrhea vomiting nausea 59 TKB# 59 severe renal impairment 59 VBLOC vagal blocking 59 Epratuzumab 59 transthyretin TTR mediated amyloidosis 59 intermittent hemodialysis 59 MYLOTARG 59 Phase III multicenter 59 Retisert ® 59 CK # administered 59 humanized therapeutic 59 cytidine nucleoside analog 59 cytopenias 59 gastroenterology neurology 59 hormone LHRH antagonist 59 Plaquenil 59 SinuNase ™ 59 Archexin 59 MELAS 59 Cancidas 59 Neovascular 59 Aggrastat ® tirofiban hydrochloride 59 rALLy 59 Hypertrophic 59 pheochromocytoma 59 IV NSCLC 59 RTP #i 59 investigational oral hepatitis C 59 Phase Ib II 59 Methylnaltrexone 59 investigational pharmacologically unique 59 polyarticular 59 psoriasis inflammatory bowel 59 CTEPH 59 multicenter Phase II 59 inhaled iloprost 59 anterior uveitis 59 oncolytic virus therapies 59 arthralgias 59 r hGH 59 Augment ™ 59 subependymal giant cell 59 Myelodysplastic syndromes 59 Sudhir Agrawal D.Phil 59 Evalve MitraClip R 59 agalsidase alfa 59 Vascugel 59 TM pralatrexate injection 59 Monoclonal antibody 59 keloid scarring 59 adenosine injection 59 progressive neurodegenerative 59 evaluating T DM1 59 liver resection 59 lutropin alfa 59 Diabetic Macular Edema 59 prospective randomized multicenter 59 coadministration 59 failure ADHF 59 Mitomycin C 59 Aneurysm Repair 59 Azacitidine 59 anti botulism antibody 59 Gemzar gemcitabine 59 superficial femoral 59 Acute Attacks 59 pulmonary alveolar 59 Kuvan R 59 mapatumumab 59 initiate Phase IIa 59 AFREZZA TM 59 Forodesine 59 functional mitral regurgitation 59 resectable pancreatic cancer 59 Albuferon TM 59 carcinoid syndrome 59 enhanced external counterpulsation 59 Phase III Pivotal 59 TELINTRA R 59 vascular occlusive diseases 59 melphalan prednisone 59 registrational Phase 59 rheumatoid arthritis Crohn disease 59 galiximab 59 SomatoKine 59 HBeAg negative patients 59 soluble tumor necrosis 59 Peripheral Arterial 59 Onrigin 59 symptomatic benign prostatic 59 Sapacitabine 59 nephropathic cystinosis 59 Pancreas Cancer Vaccine 59 PLX MS 59 including eniluracil ADH 59 gemcitabine Gemzar ® 59 doxepin HCl 59 underwent resection 59 suppurative 59 Cerebril TM 59 hour bronchodilation 59 metformin sulfonylureas 59 anti muscarinic 59 Electronic Brachytherapy System 59 Chronic Renal Failure 59 neuromuscular spasm 59 oral Janus kinase 59 myeloproliferative disorder 59 heparin induced thrombocytopenia 59 immunocompetent patients 59 Eisenmenger syndrome 59 IL# PE#QQR 59 including acne photodamage 59 AVONEX ® 59 Medidur TM FA 59 oral ridaforolimus 59 intracavitary 59 neovascular form